Overexpression of TYMS in pancreatic cancer leads to a decrease in overall survival and relapse-free survival, which is a biomarker for diagnosis and prognosis of pancreatic cancer (Fu et al., 2019). This evidence concerns the gene TYMS and familial pancreatic carcinoma.